| 1 |
Esim O, Hascicek C. Cancer Nanotheranostics. Advances in Novel Formulations for Drug Delivery 2023. [DOI: 10.1002/9781394167708.ch22] [Reference Citation Analysis]
|
| 2 |
Kaynak A, Davis HW, Vallabhapurapu SD, Pak KY, Gray BD, Qi X. SapC-DOPS as a Novel Therapeutic and Diagnostic Agent for Glioblastoma Therapy and Detection: Alternative to Old Drugs and Agents. Pharmaceuticals (Basel) 2021;14:1193. [PMID: 34832975 DOI: 10.3390/ph14111193] [Reference Citation Analysis]
|
| 3 |
Chang CH, Chang MC, Chang YJ, Chen LC, Lee TW, Ting G. Translating Research for the Radiotheranostics of Nanotargeted 188Re-Liposome. Int J Mol Sci 2021;22:3868. [PMID: 33918011 DOI: 10.3390/ijms22083868] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 4 |
Jeyamogan S, Khan NA, Siddiqui R. Application and Importance of Theranostics in the Diagnosis and Treatment of Cancer. Arch Med Res 2021;52:131-42. [PMID: 33423803 DOI: 10.1016/j.arcmed.2020.10.016] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 5 |
Shah MR, Imran M, Ullah S. Liposome-based targeted delivery of anticancer drugs for effective therapy of brain tumors. Nanocarriers for Cancer Diagnosis and Targeted Chemotherapy 2019. [DOI: 10.1016/b978-0-12-816773-1.00003-1] [Reference Citation Analysis]
|
| 6 |
Farzin L, Sheibani S, Moassesi ME, Shamsipur M. An overview of nanoscale radionuclides and radiolabeled nanomaterials commonly used for nuclear molecular imaging and therapeutic functions. J Biomed Mater Res A 2019;107:251-85. [PMID: 30358098 DOI: 10.1002/jbm.a.36550] [Cited by in Crossref: 49] [Cited by in F6Publishing: 52] [Article Influence: 9.8] [Reference Citation Analysis]
|
| 7 |
Lamichhane N, Udayakumar TS, D'Souza WD, Simone CB 2nd, Raghavan SR, Polf J, Mahmood J. Liposomes: Clinical Applications and Potential for Image-Guided Drug Delivery. Molecules 2018;23:E288. [PMID: 29385755 DOI: 10.3390/molecules23020288] [Cited by in Crossref: 137] [Cited by in F6Publishing: 144] [Article Influence: 27.4] [Reference Citation Analysis]
|
| 8 |
Séhédic D, Chourpa I, Tétaud C, Griveau A, Loussouarn C, Avril S, Legendre C, Lepareur N, Wion D, Hindré F, Davodeau F, Garcion E. Locoregional Confinement and Major Clinical Benefit of 188Re-Loaded CXCR4-Targeted Nanocarriers in an Orthotopic Human to Mouse Model of Glioblastoma. Theranostics 2017;7:4517-36. [PMID: 29158842 DOI: 10.7150/thno.19403] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 6.2] [Reference Citation Analysis]
|
| 9 |
Gutiérrez L, Stepien G, Gutiérrez L, Pérez-hernández M, Pardo J, Pardo J, Grazú V, de la Fuente J. Nanotechnology in Drug Discovery and Development. Comprehensive Medicinal Chemistry III 2017. [DOI: 10.1016/b978-0-12-409547-2.12292-9] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 10 |
Zhao J, Zhou M, Li C. Synthetic nanoparticles for delivery of radioisotopes and radiosensitizers in cancer therapy. Cancer Nanotechnol 2016;7:9. [PMID: 27909463 DOI: 10.1186/s12645-016-0022-9] [Cited by in Crossref: 33] [Cited by in F6Publishing: 36] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 11 |
Vieira DB, Gamarra LF. Getting into the brain: liposome-based strategies for effective drug delivery across the blood-brain barrier. Int J Nanomedicine 2016;11:5381-414. [PMID: 27799765 DOI: 10.2147/IJN.S117210] [Cited by in Crossref: 219] [Cited by in F6Publishing: 236] [Article Influence: 31.3] [Reference Citation Analysis]
|
| 12 |
Li D, Chen H, Bi F, Wang Z. Progress of Multimodal Molecular Imaging Technology in Diagnosis of Tumor. Chinese Journal of Analytical Chemistry 2016;44:1609-18. [DOI: 10.1016/s1872-2040(16)60966-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 13 |
Knapp FF, Dash A. Moving Forward: Expected Opportunities for the Development of New Therapeutic Agents Based on Nanotechnologies. Radiopharmaceuticals for Therapy 2016. [DOI: 10.1007/978-81-322-2607-9_16] [Reference Citation Analysis]
|
| 14 |
Chen W, Huang FJ, Chang H, Lee T, Chang C, Lo J. The novel preparation of 99mTc(I)-labeled human serum albumin (HSA) nanoparticles as a SPECT imaging agent. J Radioanal Nucl Chem 2016;307:141-50. [DOI: 10.1007/s10967-015-4094-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 15 |
Bernsen MR, Vaissier PE, Van Holen R, Booij J, Beekman FJ, de Jong M. The role of preclinical SPECT in oncological and neurological research in combination with either CT or MRI. Eur J Nucl Med Mol Imaging 2014;41 Suppl 1:S36-49. [PMID: 24895751 DOI: 10.1007/s00259-013-2685-3] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 16 |
Ostrowski A, Nordmeyer D, Boreham A, Holzhausen C, Mundhenk L, Graf C, Meinke MC, Vogt A, Hadam S, Lademann J, Rühl E, Alexiev U, Gruber AD. Overview about the localization of nanoparticles in tissue and cellular context by different imaging techniques. Beilstein J Nanotechnol 2015;6:263-80. [PMID: 25671170 DOI: 10.3762/bjnano.6.25] [Cited by in Crossref: 66] [Cited by in F6Publishing: 66] [Article Influence: 8.3] [Reference Citation Analysis]
|
| 17 |
Huang FY, Lee TW, Chang CH, Chen LC, Hsu WH, Chang CW, Lo JM. Evaluation of 188Re-labeled PEGylated nanoliposome as a radionuclide therapeutic agent in an orthotopic glioma-bearing rat model. Int J Nanomedicine 2015;10:463-73. [PMID: 25624760 DOI: 10.2147/IJN.S75955] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 18 |
Kaittanis C, Shaffer TM, Thorek DL, Grimm J. Dawn of advanced molecular medicine: nanotechnological advancements in cancer imaging and therapy. Crit Rev Oncog 2014;19:143-76. [PMID: 25271430 DOI: 10.1615/critrevoncog.2014011601] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 19 |
Phillips WT, Bao A, Brenner AJ, Goins BA. Image-guided interventional therapy for cancer with radiotherapeutic nanoparticles. Adv Drug Deliv Rev 2014;76:39-59. [PMID: 25016083 DOI: 10.1016/j.addr.2014.07.001] [Cited by in Crossref: 59] [Cited by in F6Publishing: 66] [Article Influence: 6.6] [Reference Citation Analysis]
|
| 20 |
Dawidczyk CM, Russell LM, Searson PC. Nanomedicines for cancer therapy: state-of-the-art and limitations to pre-clinical studies that hinder future developments. Front Chem 2014;2:69. [PMID: 25202689 DOI: 10.3389/fchem.2014.00069] [Cited by in Crossref: 88] [Cited by in F6Publishing: 99] [Article Influence: 9.8] [Reference Citation Analysis]
|
| 21 |
Huang FJ, Gan G, Lin W, Huang L, Luo T, Hong J, Hsieh B. Investigation of the local delivery of an intelligent chitosan-based 188Re thermosensitive in situ-forming hydrogel in an orthotopic hepatoma-bearing rat model. J Radioanal Nucl Chem 2014;299:31-40. [DOI: 10.1007/s10967-013-2742-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 22 |
Liu G, Mao J, Jiang Z, Sun T, Hu Y, Jiang Z, Zhang C, Dong J, Huang Q, Lan Q. Transferrin-modified Doxorubicin-loaded biodegradable nanoparticles exhibit enhanced efficacy in treating brain glioma-bearing rats. Cancer Biother Radiopharm 2013;28:691-6. [PMID: 23786401 DOI: 10.1089/cbr.2013.1480] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 23 |
Huang FY, Chen WJ, Lee WY, Lo ST, Lee TW, Lo JM. In vitro and in vivo evaluation of lactoferrin-conjugated liposomes as a novel carrier to improve the brain delivery. Int J Mol Sci 2013;14:2862-74. [PMID: 23434652 DOI: 10.3390/ijms14022862] [Cited by in Crossref: 49] [Cited by in F6Publishing: 54] [Article Influence: 4.9] [Reference Citation Analysis]
|
